Hi, what are you looking for?
Jewish Business News
Search results for "PERIGGO"
Mergers & Acquisitions
Generic drug maker Mylan $26bn hostile bid for peer Perrigo looked unlikely to succeed, a few hours before it was set to expire, a...
Business
Perrigo Company Plc, the Irish-based generic drugmaker trying to fend off a hostile bid by Mylan NV, held unsuccessful talks to acquire Endo International...
Business
Mylan begins trading on the TASE; agrees to sell rights and assets related to seven generic drugs to secure regulatory approval of its hostile...
Business
Regulator tells Migdal Insurance to rescind giant dividend; Noble Energy posts wider-than-expected loss for the third quarter; Pharma, telecom shares lead Tel Aviv higher.
Business
Court rules that Mylan provided adequate public disclosures.
Business
6% workforce reduction, $2 billion in stock repurchases and vitamin unit sale in the offing
Business
The hostile takeover bid for Perrigo Co. PLC continues with Mylan NV hosting a Tuesday, 5 pm, conference call to pitch the buyout...
Business
The Generic-drug maker took its bid directly to shareholders after being rebuffed since April
Business
Mylan N.V. (NASDAQ: MYL) shareholders have approved Mylan’s proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE). The transaction received the approval of two-thirds of...
Business
Joseph Papa scathingly dismisses Mylan's latest tactic in lowering the stake it wants to buy in Perrigo. "today's announcement makes it even worse"